Keyvan Rezaï

2.8k citations
57 papers · 2.4k · h-index 21

Impact in

    • Protein Degradation and Inhibitors
    • Epigenetics and DNA Methylation
    • Chromatin Remodeling and Cancer
    • Genomics and Chromatin Dynamics
  • Neurology top 5%
    • CNS Lymphoma Diagnosis and Treatment

Papers in

    • HER2/EGFR in Cancer Research 6
    • Drug Transport and Resistance Mechanisms 5
    • Pharmacogenetics and Drug Metabolism 10

Keyvan Rezaï

57 papers receiving 2.3k citations

Peers

Keyvan Rezaï
Comparison fields: 5 of 76
  • Molecular Biology 1.2k
  • Neurology 212
  • Oncology 289
  • Genetics 93
  • Cancer Research 138
Replace Peter T. C. Ho with:
Peter T. C. Ho United States
Susan Korenchuk United States
Aidan G. Gilmartin United States
Ensar Halilovic United States
Raushan T. Kurmasheva United States
William T. Senapedis United States
Sonal K. Patel United States
Aya Kita Japan
Zhan Yao United States
Kimberly N. Smitheman United States
Keyvan Rezaï relative to Peter T. C. Ho United States Peter T. C. Ho's profile →
Citations per field
00.5×2×3.2×
Peter T. C. Ho · 1×
Citations per year

Countries citing papers authored by Keyvan Rezaï

Since Specialization
Citations

This map shows the geographic impact of Keyvan Rezaï's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyvan Rezaï with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyvan Rezaï more than expected).

Fields of papers citing papers by Keyvan Rezaï

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyvan Rezaï. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyvan Rezaï. The network helps show where Keyvan Rezaï may publish in the future.

Co-authors

The 25 scholars most cited alongside Keyvan Rezaï, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keyvan Rezaï Line = papers co-authored together Keyvan Rezaï links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016380
2 2016372
3 2018238
4 2019230
5 2016132
6 201993
7 201689
8 201586
9 201653
10 201753
11 201349
12 201243
13 200529
14 202129
15 201028
16 201527
17 201625
18 201625
19 201825
20 201821

About Keyvan Rezaï

Keyvan Rezaï is a scholar working on Oncology, Pharmacology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (14 papers), Pharmacogenetics and Drug Metabolism (10 papers), HER2/EGFR in Cancer Research (6 papers), Cancer therapeutics and mechanisms (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Breast Cancer Treatment Studies (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Neurology (212 citations), Oncology (289 citations), Genetics (93 citations) and Cancer Research (138 citations). Keyvan Rezaï has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Francois Marc Lokiec, Patrice Herait, Anastasios Stathis, Carmen Maria Kahatt, Mohamed Békradda, Marı́a Eugenia Riveiro, Esteban Cvitkovic, Elodie Odore, Emmanuel Raffoux and Bruno Quesnel. Their work appears in journals such as European Journal of Cancer, Cancer Chemotherapy and Pharmacology, Oncotarget, British Journal of Cancer and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact